Bringing a Cancer Doctor’s Perspective to FDA’s Response to the COVID-19 Pandemic

In hospitals all across this country, doctors continue to deal with the influx of COVID-19 cases. As a doctor, my heart breaks for the patients and their families. I also want to express admiration for my peers in the medical community who are doing everything they can to treat patients ill with this novel disease that we continue to learn about every day.

At the FDA, our public health concern is for the American people, and much like the health care professionals on the frontlines, our team of 18,000 strong are using their years of expertise to make decisions based on the best science and data at hand during this unparalleled public health emergency.

One area where there’s been tremendous public interest is potential prevention and treatment options. The FDA plays a pivotal role in this work to both help move new medical products to patients as soon as possible, while at the same time determine whether they are effective and if the benefits outweigh the risks.

Read More